This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Kinoxis Therapeutics Pty Ltd, The University of Sydney. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New South Wales, AU (2020 - 2022)
- The University of Sydney, AU (2022)
Company Filing History:
Years Active: 2020-2022
Title: The Innovative Contributions of Tristan Reekie
Introduction
Tristan Reekie is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of 3 patents to his name, Reekie's work is characterized by a focus on innovative therapeutic solutions.
Latest Patents
Reekie's latest patents include groundbreaking research on non-peptide oxytocin receptor agonists. These patents disclose compounds that are designed to treat disorders characterized by disruptions in social behavior and substance use. The pharmaceutical compositions he developed consist of a pharmaceutically acceptable compound and a carrier, diluent, or excipient. Additionally, he has worked on metabolite-inspired selective oxytocin receptor agonists, which are cyclic metabolites of oxytocin that exhibit enhanced selectivity for the oxytocin receptor.
Career Highlights
Throughout his career, Tristan Reekie has been associated with prominent organizations such as Kinoxis Therapeutics Pty Ltd and The University of Sydney Commercial Development & Industry Partnerships. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic agents.
Collaborations
Reekie has collaborated with esteemed colleagues, including Michael Kassiou and William Jorgensen. These partnerships have further enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Tristan Reekie's innovative contributions to the field of pharmaceutical sciences highlight his commitment to addressing complex neurological and psychiatric disorders. His patents and collaborations reflect a dedication to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile